Live feed
·
INSIDERFiling
CRISPR Therapeutics AG logo

General Counsel and Secretary Kasinger James R. converted options into 5,500 shares and sold $147,840 worth of shares (2,800 units at $52.80), increasing direct ownership by 3% to 87,815 units (SEC Form 4)